Loading viewer...
investor_presentation
Format: PDF investor_presentation
Mid-year business update presented on August 4, 2016, covering genomic medicine approach, anti-LIGHT program overview, and financial milestones. The presentation outlines the company's progress, strategic initiatives, and forward-looking performance expectations.
investor_presentation
18 Pages
investor_presentation
25 Pages
Kintara Therapeutics, Inc.
Regeneron Pharmaceuticals Investor Presentation — May 2022
investor_presentationinvestor_presentation
22 Pages
Regeneron Pharmaceuticals, Inc.
Tonix Pharmaceuticals Holding Investor Presentation — January 2021
investor_presentationinvestor_presentation
66 Pages
Tonix Pharmaceuticals Holding Corp.